# | Title | Journal | Year | Citations |
---|
1 | Acute Lung Injury: Epidemiology, Pathogenesis, and Treatment | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2010 | 578 |
2 | The Mechanism of Breath Aerosol Formation | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2009 | 341 |
3 | Aerosol Deposition in Health and Disease | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2012 | 297 |
4 | Update on Macrophage Clearance of Inhaled Micro- and Nanoparticles | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2010 | 273 |
5 | Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2011 | 268 |
6 | The History of Therapeutic Aerosols: A Chronological Review | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2017 | 194 |
7 | The Particle has Landed—Characterizing the Fate of Inhaled Pharmaceuticals | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2010 | 191 |
8 | Predictors of Incorrect Inhalation Technique in Patients with Asthma or COPD: A Study Using a Validated Videotaped Scoring Method | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2010 | 181 |
9 | Role of Cilia, Mucus, and Airway Surface Liquid in Mucociliary Dysfunction: Lessons from Mouse Models | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2008 | 165 |
10 | Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for Asthma and COPD Patients | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2016 | 146 |
11 | Aerosol Delivery During Mechanical Ventilation: From Basic Techniques to New Devices | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2008 | 142 |
12 | Lung Deposition of BDP/Formoterol HFA pMDI in Healthy Volunteers, Asthmatic, and COPD Patients | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2010 | 139 |
13 | An Open Label, Pilot Study of Aerosurf®Combined with nCPAP to Prevent RDS in Preterm Neonates | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2010 | 138 |
14 | Origin of Exhaled Breath Particles from Healthy and Human Rhinovirus-Infected Subjects | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2011 | 132 |
15 | Breathing Is Enough: For the Spread of Influenza Virus and SARS-CoV-2 by Breathing Only | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2020 | 131 |
16 | In Vitro/In VivoComparisons in Pulmonary Drug Delivery | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2008 | 129 |
17 | Aerosolized Chemotherapy | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2008 | 120 |
18 | Nasal Deposition and Clearance in Man: Comparison of a Bidirectional Powder Device and a Traditional Liquid Spray Pump | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2012 | 119 |
19 | Validation of a General In Vitro Approach for Prediction of Total Lung Deposition in Healthy Adults for Pharmaceutical Inhalation Products | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2013 | 113 |
20 | Measurement Techniques for Respiratory Tract Deposition of Airborne Nanoparticles: A Critical Review | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2014 | 111 |
21 | Air Pollution During Pregnancy and Neonatal Outcome: A Review | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2013 | 105 |
22 | Interindividual Variability in Nasal Filtration as a Function of Nasal Cavity Geometry | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2009 | 100 |
23 | Characterization of Exhaled Particles from the Healthy Human Lung—A Systematic Analysis in Relation to Pulmonary Function Variables | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2010 | 100 |
24 | In VitroTests for Aerosol Deposition. I: Scaling a Physical Model of the Upper Airways to Predict Drug Deposition Variation in Normal Humans | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2012 | 98 |
25 | Aerosol Delivery through Nasal Cannulas: An In Vitro Study | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2008 | 97 |
26 | Combined Determination of the Chemical Composition and of Health Effects of Secondary Organic Aerosols: The POLYSOA Project | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2008 | 95 |
27 | Evaluation of the Respimat Soft Mist Inhaler using a Concurrent CFD and In Vitro Approach | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2009 | 95 |
28 | In Vivo–In VitroCorrelations: Predicting Pulmonary Drug Deposition from Pharmaceutical Aerosols | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2010 | 93 |
29 | Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2010 | 93 |
30 | Comparison of Deposition in the USP and Physical Mouth–Throat Models with Solid and Liquid Particles | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2011 | 93 |
31 | Recent Advances in Predictive Understanding of Respiratory Tract Deposition | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2008 | 92 |
32 | Inhalation Therapy in Patients Receiving Mechanical Ventilation: An Update | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2012 | 92 |
33 | Characterization of Nebulized Liposomal Amikacin (Arikace™) as a Function of Droplet Size | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2008 | 91 |
34 | Pulmonary Formulations: What Remains to be Done? | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2010 | 91 |
35 | Global Burden of Chronic Respiratory Diseases | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2020 | 90 |
36 | A Gamma Scintigraphy Study to Investigate Lung Deposition and Clearance of Inhaled Amikacin-Loaded Liposomes in Healthy Male Volunteers | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2009 | 88 |
37 | Standardization of Techniques for Using Planar (2D) Imaging for Aerosol Deposition Assessment of Orally Inhaled Products | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2012 | 87 |
38 | Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2017 | 86 |
39 | Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2020 | 85 |
40 | New Pharmacotherapy for Airway Mucus Hypersecretion in Asthma and COPD: Targeting Intracellular Signaling Pathways | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2010 | 84 |
41 | The Inhalation Characteristics of Patients When They Use Different Dry Powder Inhalers | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2015 | 84 |
42 | In VitroTests for Aerosol Deposition II: IVIVCs for Different Dry Powder Inhalers in Normal Adults | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2013 | 81 |
43 | The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2020 | 81 |
44 | Aerosol Therapy in Adults Receiving High Flow Nasal Cannula Oxygen Therapy | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2016 | 80 |
45 | Deposition Mechanisms | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2020 | 80 |
46 | Prevalence and COPD Phenotype for a Suboptimal Peak Inspiratory Flow Rate against the Simulated Resistance of the Diskus® Dry Powder Inhaler | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2013 | 79 |
47 | Influence of Particle Size and Material Properties on Mucociliary Clearance from the Airways | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2010 | 78 |
48 | Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler® in Comparison with Diskus® and Turbohaler® Dry Powder Inhalers | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2016 | 78 |
49 | The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2015 | 77 |
50 | Inhaled Prostanoids in the Therapy of Pulmonary Hypertension | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 2008 | 76 |